These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18496721)

  • 21. Conditionally funded field evaluations and practical trial design within a health technology assessment framework.
    Bowen JM; Patterson LL; O'Reilly D; Hopkins RB; Blackhouse G; Burke N; Xie F; Tarride JE; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):324-31. PubMed ID: 19394573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regarding probabilistic analysis and computationally expensive models: necessary and required?
    Caro JJ; Getsios D; Möller J
    Value Health; 2007; 10(4):317-8; author reply 319. PubMed ID: 17645686
    [No Abstract]   [Full Text] [Related]  

  • 23. Guiding the process of health technology disinvestment.
    Ibargoyen-Roteta N; Gutiérrez-Ibarluzea I; Asua J
    Health Policy; 2010 Dec; 98(2-3):218-26. PubMed ID: 20638745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ICER is good for us--Possibly not for you, he or she.
    Pekurinen M
    Int J Technol Assess Health Care; 2011 Jan; 27(1):98. PubMed ID: 21262090
    [No Abstract]   [Full Text] [Related]  

  • 25. Resource allocation and health technology assessment in Australia: views from the local level.
    Gallego G; van Gool K; Kelleher D
    Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical conflicts in health care technology.
    Harris DJ
    Midwest Med Ethics; 1992; 8(1):30-3. PubMed ID: 16038078
    [No Abstract]   [Full Text] [Related]  

  • 27. Approaches for economic evaluations of health care technologies.
    Tarride JE; Blackhouse G; Bischof M; McCarron EC; Lim M; Ferrusi IL; Xie F; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):307-16. PubMed ID: 19394571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics.
    Retèl VP; Bueno-de-Mesquita JM; Hummel MJ; van de Vijver MJ; Douma KF; Karsenberg K; van Dam FS; van Krimpen C; Bellot FE; Roumen RM; Linn SC; van Harten WH
    Int J Technol Assess Health Care; 2009 Jan; 25(1):73-83. PubMed ID: 19126254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health technology assessment: regulators or payers--who will take the lead?
    Jönsson B
    Clin Ther; 2008 May; 30(5):960-3. PubMed ID: 18555942
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-effectiveness analysis and innovation.
    Jena AB; Philipson TJ
    J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Policy making and roles of health technology assessment.
    Tantivess S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S88-99. PubMed ID: 19253491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Making health technology assessment information available for decision making: the development of a Thai database.
    Kapol N; Maitreemit P; Chalongsuk R; Amrumpai Y; Sribundit N; Thavorncharoensap M; Chaikledkaew U; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S8-10. PubMed ID: 19253482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of clinical effects.
    Teerawattananon Y; Thavorncharoensap M; Mohara A
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S38-42. PubMed ID: 19253486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Innovative development of medical science].
    Pal'tsev MA
    Vestn Ross Akad Med Nauk; 2011; (2):14-8. PubMed ID: 21516727
    [No Abstract]   [Full Text] [Related]  

  • 35. Save money by understanding variance and tolerancing.
    Stuart K
    Med Device Technol; 2007; 18(3):40, 42-3. PubMed ID: 17585721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of Technology on Surgery: The Future Is Unwritten.
    Morino M
    Ann Surg; 2018 Nov; 268(5):709-711. PubMed ID: 30048330
    [No Abstract]   [Full Text] [Related]  

  • 37. Thai health technology assessment guideline development.
    Teerawattananon Y; Chaikledkaew U
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S11-5. PubMed ID: 19253483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based decision-making for diagnostic and therapeutic methods: the changing landscape of assessment approaches in Germany.
    Olberg B; Fuchs S; Matthias K; Nolting A; Perleth M; Busse R
    Health Res Policy Syst; 2017 Oct; 15(1):89. PubMed ID: 29041939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introducing new health interventions.
    Gabbay J; Walley T
    BMJ; 2006 Jan; 332(7533):64-5. PubMed ID: 16410559
    [No Abstract]   [Full Text] [Related]  

  • 40. Technology in healthcare: leveraging new innovations.
    Larsen MG
    Healthc Exec; 2008; 23(5):8-10, 12-4. PubMed ID: 18788350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.